Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS.

Li, Meng; Zhang, Qing-Song; Liu, Xin-Ling; Wang, Hui-Ling; Liu, Wei

Li, Meng; Zhang, Qing-Song; Liu, Xin-Ling; Wang, Hui-Ling; Liu, Wei.

Afiliación

Li M; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Zhang QS; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Liu XL; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Wang HL; School of Pharmaceutical Sciences, Zhengzhou Railway Vocational and Technical College, Zhengzhou 450002, China.
Liu W; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Pharmaceuticals (Basel) ; 15(12)2022 Nov 24.

Article en En | MEDLINE | ID: mdl-36558906

Palabras clave

COVID-19; FAERS; adverse drug reaction; nirmatrelvir/ritonavir; pharmacovigilance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google